Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
10.
Can Anaesth Soc J ; 28(2): 114-20, 1981 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7248820

RESUMO

The drug 4-aminopyridine (4-AP) at a dose of 0.2 mg . kg-1 body weight intravenously is an effective antagonist of non-depolarizing neuromuscular blockade. We studied its cardiovascular effects in the canine heart using a right-heart bypass with extracorporeal circulation in seven dogs. This study demonstrates that 4-aminopyridine significantly augments arterial blood pressure, left ventricular dp/dt maximum, as well as left ventricular pressure at dp/dt mx. The highest values were obtained between two and 20 minutes after administration of 4-AP. Left ventricular end-diastolic pressure diminished slightly, but this was not statistically significant. Although the exact mechanism of action of 4-AP is not known, its positive inotropic effects may be of value in the reversal of non-depolarizing neuromuscular blockade in patients with impaired myocardial function of diverse aetiologies and it would be contra-indicated in patients with arterial hypertension and/or coronary artery disease.


Assuntos
Aminopiridinas/farmacologia , Sistema Cardiovascular/efeitos dos fármacos , Fármacos Neuromusculares Despolarizantes/farmacologia , 4-Aminopiridina , Animais , Pressão Sanguínea/efeitos dos fármacos , Cães
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA